31-May-2026 Breakthrough in cancer immunotherapy: Dresden researchers present promising therapy for advanced solid tumors Technische Universität Dresden Peer-Reviewed Publication
31-May-2026 RAS(ON) inhibitor doubles median overall survival in results of phase 3 trial for patients with metastatic pancreatic cancer Dana-Farber Cancer Institute Peer-Reviewed Publication
31-May-2026 Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis and death Dana-Farber Cancer Institute Peer-Reviewed Publication
30-May-2026 Cancer diagnostic delay rates associated with a population-based screening trial evaluating a cell-free DNA multicancer early detection test JAMA Network Peer-Reviewed Publication
30-May-2026 New AI approach aims to predict radiation dose before therapy in advanced prostate cancer Society of Nuclear Medicine and Molecular Imaging Peer-Reviewed Publication
30-May-2026 A peptide-targeted, hypoxia-responsive adeno-associated virus platform for tumor-selective delivery of chemokines and PNAi in non-small cell lung cancer Xia & He Publishing Inc. Peer-Reviewed Publication
30-May-2026 ASCO: Tile-based radiation therapy lowers risk of recurrence in brain metastases University of Texas M. D. Anderson Cancer Center Reports and Proceedings
29-May-2026 Study: Lung biopsy cryoprobe increases diagnostic yield over standard forceps Vanderbilt University Medical Center Peer-Reviewed Publication
29-May-2026 Addition of immunotherapy continues to show survival benefit in prolonged follow-up in NRG Oncology trial for primary advanced stage or recurrent endometrial cancer NRG Oncology Reports and Proceedings
29-May-2026 Researchers from NYU Langone Health’s Perlmutter Cancer Center present latest findings at 2026 ASCO Annual Meeting NYU Langone Health / NYU Grossman School of Medicine Meeting Announcement